Yeon Hee Park
Samsung Medical Center(KR)Sungkyunkwan University(KR)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Monoclonal and Polyclonal Antibodies Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → Pembrolizumab for Early Triple-Negative Breast Cancer(2020)2,944 cited
- → Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer(2022)2,396 cited
- → Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer(2019)1,885 cited
- → Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer(2017)1,041 cited
- → Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer(2023)619 cited
- → Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study(2020)443 cited
- → Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study